Skip to content

Drug interactions

Fosaprepitant + Ivabradine

Severity: Moderate

Fosaprepitant and Ivabradine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Fosaprepitant, converted to aprepitant, is a moderate CYP3A4 inhibitor and can raise ivabradine exposure. This may cause bradycardia, though a single dose has a transient effect.

What this interaction means in plain words

Fosaprepitant and Ivabradine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Fosaprepitant belongs to Gastrointestinal Tract; Ivabradine belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Aprepitant inhibits CYP3A4, reducing ivabradine metabolism.

What to do

Monitor heart rate and ECG for several days after dosing. Consider holding or lowering ivabradine if bradycardia develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fosaprepitant and Ivabradine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Fosaprepitant with Ivabradine?

MediHelp rates the interaction as moderate. Fosaprepitant and Ivabradine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Fosaprepitant, converted to aprepitant, is a moderate CYP3A4 inhibitor and can raise ivabradine exposure. This may cause bradycardia, though a single dose has a transient effect.

How serious is the interaction between Fosaprepitant and Ivabradine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor heart rate and ECG for several days after dosing. Consider holding or lowering ivabradine if bradycardia develops.

What other medicines interact with Ivabradine?

MediHelp also lists interactions of Ivabradine with, for example, Atazanavir, Clarithromycin, Cobicistat. The full list is on the Ivabradine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in